Allergy Immunotherapy Market Overview, Analysis And Demand By 2034


Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the allergy immunotherapy sector.

What Is The Current Outlook For The Allergy Immunotherapy Market?
The allergy immunotherapy market size has grown strongly in recent years. It will grow from $2.88 billion in 2024 to $3.16 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing incidence of allergic diseases, advancements in immunotherapy techniques, growing awareness among patients, government initiatives, improvements in research and development.

The allergy immunotherapy market size is expected to see rapid growth in the next few years. It will grow to $5.03 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to rising global allergy burden, healthcare policy support, increasing acceptance of immunotherapy, emerging markets and untapped regions, increasing healthcare expenditure. Major trends in the forecast period include advancements in treatment technology, increasing allergy prevalence, rise in patient awareness and education, telemedicine and remote monitoring, customized treatment plans.

Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9416&type=smp

What Are The Driving Factors Impacting The Allergy Immunotherapy Market?
The rising prevalence of allergic disorders is expected to propel the growth of the allergy immunotherapy market going forward. Allergic disorders refer to excessive immune responses to specific antigens. Immune responses that are inappropriately directed against intrinsic bodily parts (self) result in autoimmune diseases. Allergy immunotherapy is available to atopic people who have allergy disorders like IgE-mediated allergic rhinitis and allergic asthma brought on by inhaled allergens, including pollens and house dust mites (HDMs). For instance, in August 202, according to the Medicines and Healthcare Products Regulatory Agency (MHRA), a UK-based executive agency published that in 2022-23, English hospitals recorded over 25,000 admissions for allergies and anaphylaxis, more than twice the number seen in the last twenty years. Additionally, in May 2024, according to the Food Standards Agency, a UK-based government department published the Patterns and Prevalence of Adult Food Allergy (PAFA) report that around 6% of adults in the UK are affected by food allergies, which is approximately 2.4 million individuals. Therefore, the rising prevalence of allergic disorders is driving the growth of the allergy immunotherapy market.

Analysis Of Major Segments Driving The Allergy Immunotherapy Market Growth
The allergy immunotherapymarket covered in this report is segmented –

1) By Allergy Type: Allergic Rhinitis; Asthma; Food Allergy; Venom Allergy; Other Allergy Types
2) By Treatment: Subcutaneous Immunotherapy (SCIT); Sublingual Immunotherapy; Specific Immunotherapy (SIT)
3) By Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

Subsegments:
1) By Allergic Rhinitis: Seasonal Allergic Rhinitis; Perennial Allergic Rhinitis
2) By Asthma: Allergic Asthma; Non-Allergic Asthma
3) By Food Allergy: Peanut Allergy; Tree Nut Allergy; Milk Allergy; Egg Allergy; Other Food Allergies
4) By Venom Allergy: Insect Sting Allergy; Other Venom Allergies
5) By Other Allergy Types: Allergic Conjunctivitis; Eczema; Drug Allergies; Other Environmental Allergies

What Are The Upcoming Trends Of Allergy Immunotherapy Market In The Globe?
Major companies operating in the allergy immunotherapy market are innovating technological products, such as the artificial intelligence (AI)-powered allergy component testing, to sustain their position in the market. Artificial intelligence (AI)-powered allergy component testing is a novel testing platform based on component resolved diagnostics (CRD) for diagnosing various forms of allergies. For instance, in May 2023, Metropolis Healthcare Limited, an Indian-based Medical laboratory company launched artificial intelligence (AI)-powered allergy component testing. Artificial intelligence (AI)-powered allergy component testing is a fourth-generation allergy testing technology that uses Artificial Intelligence (AI) to assist clinicians in making clinical decisions. It provides great insights, selecting, and optimizing the course of treatment for allergic diseases. It is also capable of predicting the effectiveness of immunotherapy for allergy vaccinations which are effective or not.

Which Are The Top Players Involved In Allergy Immunotherapy Market?
Major companies operating in the allergy immunotherapy market include LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics plc, ALK-Abelló A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergopharma GmbH & Co. KG, Biomay AG, Anergis SA, HollisterStier Allergy, Mylan N.V., Adamis Pharmaceuticals Corporation, Desentum Oy, WOLW Pharma Limited, AllerGenics Inc., Greer Laboratories Inc., Aimmune Therapeutics Inc., Reliant Laboratories Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Danaher Corporation, QIAGEN NV, Merck & Co. Inc., Pfizer Inc., Novartis AG, GlaxoSmithKline plc, AstraZeneca plc, Sanofi SA, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd.

View the full allergy immunotherapy market report here:
https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

Which Region Drives The Most Demand In The Allergy Immunotherapy Market?
Europe was the largest region in the allergy immunotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the allergy immunotherapy market report during the forecast period. The regions covered in the allergy immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Popular posts from this blog

Paperboard Packaging Market Analysis, Share And Growth By 2025 - 2034

Unattended Terminals Market Scope, Size And Growth 2025

Freight Transport Management Market Size, Scope And Growth 2025 To 2034